LigAmp for sensitive detection of single-nucleotide differences

Nature Methods

Volumn 1, Issue 2, 2004, Pages 141-147

  Shi, Chanjuan ^a   Eshleman, Susan H ^a   Jones, Dana ^a   Fukushima, Noriyoshi ^a   Hua, Li ^a   Parker, Antony R ^a   Yeo, Charles J ^a   Hruban, Ralph H ^a   Goggins, Michael G ^a   Eshleman, James R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRAS2 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ANTIBIOTIC RESISTANCE; ARTICLE; DNA MICROARRAY; DNA SEQUENCE; EVALUATION; GENETIC SCREENING; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY;

DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; GENETIC SCREENING; HIV-1; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 13844304889     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth713     Document Type: Article

References (35)

1. Vary, C.P. et al Allele-specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonucleotide probes. Genet. Anal. 13, 59-65 (1996).
2. Chen, J. & Viola, M.V. A method to detect ras point mutations in small subpopulations of cells. Anai Biochem. 195, 51-56 (1991).
3. Redston, M.S., Papadopoulos, N., Caldas, C., Kinzler, K.W. & Kern, S.E. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108, 383-392 (1995).
4. Rothschild, C.B., Brewer, C.S., Loggie, B., Beard, G.A. & Triscott, M.X. Detection of colorectal cancer K-ras mutations using a simplified oligonucleotide ligation assay. J. Immunol. Methods 206, 11-19 (1997).
5. Clayton, S.J. et al. K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin. Chem. 46, 1929-1938 (2000).
6. Takeda, S., Ichii, S. & Nakamura, Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat. 2, 112-117 (1993).
7. Germer, S., Holland, M.J. & Higuchi, R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 10, 258-266 (2000).
8. Kwok, S. et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18, 999-1005 (1990).
9. Mc Kinzie, P.B. & Parsons, B.L. Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR. Mutat. Res. 517, 209-220 (2002).
10. Lichtenstein, A.V., Serdjuk, O.I., Sukhova, T.I., Melkonyan, H.S. & Umansky, S.R. Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS. Nucleic Acids Res. 29, E90-0 (2001).
11. Schimanski, C.C., Linnemann, U. & Berger, M.R. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res. 59, 5169-5175 (1999).
12. Kaur, M. et al Ligation of a primer at a mutation: a method to detect low-level mutations in DNA. Mutagenesis 17, 365-374 (2002).
13. Oliver, D.H., Thompson, R.E., Griffin, C.A. & Eshleman, J.R. Use of single- nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J. Mol. Diagn. 2, 202-208 (2000).
14. Srivastava, S. & Rossi, S.C. Early detection research program at the NCI. Int. J. Cancer 69, 35-37 (1996).
15. Sidransky, D. et al Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102-105 (1992).
16. Traverso, G. et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med. 346, 311-320 (2002).
17. Wilentz, R.E. et al K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82, 96-103 (1998).
18. Mulcahy, H. & Farthing, M.J. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool. Ann. Oncoi 10, 114-117 (1999).
19. Hruban, R.H., Wilentz, R.E. & Kern, S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156, 1821-1825 (2000).
20. Caldas, C. et al Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54, 3568-3573 (1994).
21. Watanabe, H. et al Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay. Pancreas 17, 341-347 (1998).
22. Tada, M. et al Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma. Dig. Dis. Sci. 43, 15-20 (1998).
23. Laghi, L. et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene 21, 4301-4306 (2002).
24. Mitchell, C.E., Belinsky, S.A. & Lechner, J.F. Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis. Anal. Biochem. 224, 148-153 (1995).
25. Prieto-Alamo, M.J. & Laval, F. Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I. Proc. Natl. Acad. Sci. USA 95, 12614-12618 (1998).
26. Ciarrocchi, G., MacPhee, D.G., Deady, L.W. & Tilley, L. Specific inhibition of the eubacterial DNA Ligase by arylamino compounds. Antimicrob. Agents Chemother. 43, 2766-2772 (1999).
27. Barringer, K.J., Orgel, L., Wahl, G. & Gingeras, T.R. Blunt-end and single-strand ligations by Escherichia coli ligase: influence on an in vitro amplification scheme. Gene 89, 117-122 (1990).
28. Schouten, J.P. et al Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).
29. Havlir, D.V., Eastman, S., Gamst, A. & Richman, D.D. Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70, 7894-7899 (1996).
30. Hirsch, M.S. et al. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society— USA Panel. JAMA 279, 1984-1991 (1998).
31. Chiu, R.W. et al. Prenatal exclusion of p-thalassaemia major by examination of maternal plasma. Lancet 360, 998-1000 (2002).
32. Yukobowich, E. et al. Risk of fetal loss in twin pregnancies undergoing second- trimester amniocentesis(l). Obstet. Gynecol. 98, 231-234 (2001).
33. Jackson, LG. et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N. Engl. J. Med. 327, 594-598 (1992).
34. Fukushima, N. et al. Diagnosing pancreatic cancer using methylation-specific PCR analysis of pancreatic juice. Cancer Biol. Ther. 2, 78-83 (2003).
35. Eshleman, S.H., Jones, D., Flys, T., Petrauskene, O. & Jackson, J.B. Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System. Biotechniques 35, 614-618, 620, 622 (2003).